QuotedData investment companies roundup November 2014
- 04 November 2014
- QuotedData
- Global
- Investment Companies
- International Biotechnology Trust : IBT
- James Carthew
QuotedData investment companies roundup November 2014
November Investment Company Monthly
Please click on the link above for our latest roundup of news; price, NAV and discount movements; and flows in and out of the sector over the month of October
full research notes Read Research Note
This website is for information purposes only and is not intended to encourage the reader to deal in any mentioned securities. Some of the content in this website is sponsored and, although it abides by Content Principles and Objectives, (/about-quoteddata/research-principles-objectives/) it is considered non-independent. Investments may involve a significant degree of risk, including loss of capital. The value of an investment and the income from it could go down as well as up. The return of your investment is not guaranteed, and you may get back less than you originally invested. Past performance is not an indicator of future performance. It is important that you read the Terms and Conditions (/about-quoteddata/terms-and-conditions/) before considering any investment.
Related Content
QuotedData’s Real Estate Roundup – April 2020
Real Estate Roundup Kindly sponsored by Aberdeen Standard Investments Performance data March’s biggest movers in price terms are shown in the chart below. Property stocks took a hammering in March […]
Investment companies quarterly roundup – Third quarter 2019
Investment Companies Quarterly Roundup Kindly sponsored by Baillie Gifford New research Over the third quarter, we published notes on India Capital Growth, Jupiter Emerging & Frontier Income, Montanaro European Smaller Companies, […]
QuotedData investment companies roundup December 2014
December Investment Companies Roundup Please click on the link above for our latest roundup of news; price, NAV and discount movements; and flows in and out of the sector over […]
AVI Japan Opportunity
CDespite the significant headwinds that have faced both Asia and growth strategies during the last 12 months, Pacific Horizon’s (PHI’s) NAV has held up so that its long-term (five- and […]
Pacific Horizon – Powered by technology
Pacific Horizon (PHI) generated a sizeable uplift in its NAV over the course of 2020. This appears to reflect its focus on growth, and technology and biotech stocks in particular. […]
Pacific Horizon – Powered by technology
Pacific Horizon (PHI) generated a very impressive uplift in its NAV over the course of 2020. This reflects its focus on growth, and technology and biotech stocks in particular. These […]
Pacific Horizon – Powered by technology
Pacific Horizon (PHI) generated a very impressive uplift in its NAV over the course of 2020. This reflects its focus on growth, and technology and biotechnology stocks in particular. These […]
Pacific Horizon – 2018 re-calibration paying off
2018 re-calibration paying off Moves by Pacific Horizon’s (PHI) manager Ewan Markson-Brown to re-position the portfolio by lowering its allocation to technology stocks, and excellent returns to-date from stock picks […]
Pacific Horizon – 2018 re-calibration paying off
2018 re-calibration paying off Moves by Pacific Horizon’s (PHI) manager Ewan Markson-Brown to re-position the portfolio by lowering the allocation to technology, and excellent returns to-date from stock picks made […]